Children Diseases and Immunizations
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Human Vaccines and Public Health".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 14140
Special Issue Editors
Interests: pediatrics; allergology; immunology; pulmonology
Special Issues, Collections and Topics in MDPI journals
Interests: pediatrics; gastroenterology; immunology; food allergy; probiotics
Special Issues, Collections and Topics in MDPI journals
Interests: neonates; neonatal care; preterm infants; nutrition; food allergy; microbiota; human milk
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the last few years, the key role of vaccinations has reemerged as one of the most important determinants of neonatal, infant and child health and, as a consequence, that of other age groups. The prevention of old and new infections still needs to be continuously empowered with appropriate campaigns to properly inform caregivers and health professionals.
A number of vaccines have been recently proposed, and new vaccines are a current matter of research. New data on fragile populations, preterm newborns, and children with chronic diseases, with immune deficiencies, with allergies and on immunosuppressive treatment demonstrate the need for a global and personalized approach. The relevance of starting immunization in pregnant women has also been shown, and new approaches have been proposed. The aim of this issue is to critically update the knowledge on vaccination programs in all pediatric ages and to help clinicians to improve the care of all pediatric populations.
Prof. Dr. Gian Luigi Marseglia
Dr. Silvia Salvatore
Prof. Dr. Massimo Agosti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- children health
- pediatrics
- allergology
- immunology
- pulmonology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.